Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy
PRKAG2 相关心肌病中 AMPK 的代谢和发育调节
基本信息
- 批准号:9182902
- 负责人:
- 金额:$ 17.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-15 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAdvisory CommitteesAffectAgonistAllelesArrhythmiaAttenuatedBiogenesisBiologyBypassCardiacCardiac MyocytesCardiomyopathiesCardiovascular DiseasesCardiovascular systemCell RespirationCell SizeCell modelCellsChemicalsChronic Kidney FailureClinicalContractile ProteinsDataDevelopmentDevelopment PlansDilated CardiomyopathyDiseaseDisease modelEngineeringEnvironmentFatty AcidsFibrosisFoundationsFunctional disorderGene MutationGeneral HospitalsGenesGeneticGenetic TranscriptionGenus HippocampusGlucoseGlycogenGoalsHeartHeart DiseasesHistopathologyHomeostasisHospitalsHumanHuman GeneticsHusbandHypertrophic CardiomyopathyHypertrophyIn VitroInheritedInstitutesInsulinInternal MedicineLabelLaboratoriesLeft Ventricular HypertrophyLinkMassachusettsMedicalMedicineMentorsMentorshipMetabolicMetabolismMitochondriaModelingMolecularMorbidity - disease rateMusMuscle CellsMutationNon-Insulin-Dependent Diabetes MellitusPI3K/AKTPRKAG2 genePathway interactionsPatientsPhysiciansPluripotent Stem CellsProcessProtein PrecursorsProto-Oncogene Proteins c-aktRegulationResearchResearch PersonnelResearch TrainingResourcesRiskRoleScientistSeriesSignal TransductionSignal Transduction PathwayStem cellsStructureSymptomsTGF Beta Signaling PathwayTechnologyTestingTrainingTraining ProgramsTransforming Growth Factor betaUnited States National Academy of SciencesVentricularWolff-Parkinson-White SyndromeWomanbasecardiogenesiscareercareer developmentcell growthdisease-causing mutationeffective therapyfatty acid metabolismfetalgenome editinggenome wide association studyglucose metabolismhuman stem cellsin vivoinduced pluripotent stem cellinnovationinsightmedical schoolsmembermetabolomicsmortalitymouse modelmutantnew therapeutic targetnext generation sequencingnovelprofessorprogramspublic health relevanceresponsesensorskillssudden cardiac deathtranscription activator-like effector nucleasestranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): This proposal details a comprehensive five-year training program for mentored career development (K08) in cardiovascular medicine for Dr. John T. Hinson. The applicant is a prior trainee in the HHMI Medical Fellows program and has completed his clinical training in Cardiovascular Medicine at Brigham and Women's Hospital and Internal Medicine at Massachusetts General Hospital through the ABIM accelerated research pathway. In this proposal, the applicant has outlined a comprehensive research-training program that leverages his prior training in human genetics and metabolism with newly acquired skills in building pluripotent stem cell models of disease, genome editing, metabolomics and flux analysis, and signal transduction, in order to shed novel insight into the mechanisms of AMPK-PRKAG2 associated cardiomyopathy. Dr. Hinson will be under the primary mentorship of Christine E. Seidman, M.D, Thomas W. Smith Professor of Medicine and Genetics at Harvard Medical School and Brigham and Women's Hospital, who is both a distinguished clinical cardiologist and member of the Howard Hughes Medical Institute and National Academy of Sciences. Dr. Seidman and her husband Dr. Jonathan Seidman are world-renown human and molecular geneticists with a focus on cardiovascular genetics. Over the last twenty years, the Seidmans have mentored countless young investigators who go on to successful, independent research careers as physician scientists. Dr. Hinson's career development plan includes educational resources at Harvard Medical School and Brigham and Women's Hospital. In addition to the resources in Dr. Seidman's state-of -the-art laboratory environment, he has gathered an advisory committee that includes world experts in genome editing and next-generation sequencing technology, mitochondrial biology, and signal transduction. The applicant's primary goals are to 1) identify how specific PRKAG2 mutations cause glycogen storage and left ventricular hypertrophy, 2) elucidate how metabolic sensing by AMPK impacts the TGF-beta signaling pathway, and finally 3) target AMPK by chemical activation in other mouse models of cardiomyopathy. Towards this, Dr. Hinson will utilize an innovative iPS model of PRKAG2-N488I cardiomyopathy created with TALEN genome editing, perform a global metabolic assessment with LC-MS combined with flux analysis of labeled substrates, and study signal transduction pathways that connect metabolic sensing by AMPK to AKT and TGF-beta pathways. Going forward, Dr. Hinson will use this career development plan to build the foundation for a career as an independent, academic physician scientist.
描述(由应用程序提供):该提案详细介绍了一项针对John T. Hinson博士心血管医学的指导职业发展五年培训计划(K08)。该申请人是HHMI医疗研究员计划的先前学员,并通过ABIM加速研究途径在Brigham和Massachusetts General Hospital的Brigham以及妇女医院和内科医学进行了心血管医学培训。在这项建议中,适用的概述了一项全面的研究培训计划,该计划利用他在人类遗传学和代谢方面的先前培训,并通过新获得的技能在构建多能疾病的干细胞模型,基因组编辑,代谢组学和磁通分析和信号翻译方面,以使Ampk-Promkag 2相关的机制为机制提供新颖的机制。 Hinson博士将在哈佛医学院的托马斯·W·史密斯医学和遗传学教授以及布里格姆和妇女医院的克里斯汀·E·塞德曼(Christine E. Seidman博士和她的丈夫Jonathan Seidman博士是世界著名的人类和分子遗传学家,重点是心血管遗传学。在过去的二十年中,Seidmans指导了无数的年轻调查员,他们继续从事物理科学家的成功,独立的研究职业。 Hinson博士的职业发展计划包括哈佛医学院,杨百翰和妇女医院的教育资源。除了Seidman博士最先进的实验室环境中的资源外,他还召集了一个咨询委员会,其中包括世界上的世界专家和下一代测序技术,线粒体生物学和信号转导。申请人的主要目标是1)确定特定的PRKAG2突变如何引起糖原储存和左心室肥大,2)阐明AMPK的代谢感应如何影响TGF-BETA信号传导途径,最后3)三)靶向AMPK通过化学型心肌病小鼠模型中的化学激活。为此,Hinson博士将利用由Talen Genome编辑创建的PRKAG2-N488I心肌病的创新IPS模型,并通过LC-MS进行全球代谢评估,并结合标记底物的通量分析,并研究信号传递途径,并通过AMPK与Akt和Tgf-Betawore的代谢敏感性连接代谢敏感性。展望未来,Hinson博士将利用这项职业发展计划为作为独立的学术医师科学家的职业建立基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Travis Hinson其他文献
John Travis Hinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Travis Hinson', 18)}}的其他基金
SCGE Disease Models Studies Supplement: Cardioediting Ttntvs in a humanized mouse model
SCGE 疾病模型研究补充:人源化小鼠模型中的心脏编辑 Ttntvs
- 批准号:
10619106 - 财政年份:2022
- 资助金额:
$ 17.71万 - 项目类别:
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing
具有先天免疫传感的人类心脏微组织用于研究基因组编辑的不良后果
- 批准号:
10463658 - 财政年份:2019
- 资助金额:
$ 17.71万 - 项目类别:
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing
具有先天免疫传感的人类心脏微组织用于研究基因组编辑的不良后果
- 批准号:
9810840 - 财政年份:2019
- 资助金额:
$ 17.71万 - 项目类别:
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing
具有先天免疫传感的人类心脏微组织用于研究基因组编辑的不良后果
- 批准号:
10245264 - 财政年份:2019
- 资助金额:
$ 17.71万 - 项目类别:
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations
具有 MYH7 突变的人三维心脏微组织等位基因、细胞和分子异质性的综合分析
- 批准号:
9983170 - 财政年份:2018
- 资助金额:
$ 17.71万 - 项目类别:
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations
具有 MYH7 突变的人三维心脏微组织等位基因、细胞和分子异质性的综合分析
- 批准号:
10210431 - 财政年份:2018
- 资助金额:
$ 17.71万 - 项目类别:
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy
PRKAG2 相关心肌病中 AMPK 的代谢和发育调节
- 批准号:
9264223 - 财政年份:2014
- 资助金额:
$ 17.71万 - 项目类别:
相似国自然基金
AMPKr2促进脂肪细胞分化的机理研究
- 批准号:81800774
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
AMPK信号通路调控多巴胺能神经元的活化介导抑郁症的发生
- 批准号:81871068
- 批准年份:2018
- 资助金额:61.0 万元
- 项目类别:面上项目
冷冻电镜技术解析AMP激活的蛋白激酶结构及构象变化
- 批准号:31860244
- 批准年份:2018
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
AMPK调控血管周围白色脂肪米色化减轻动脉粥样硬化作用机制研究
- 批准号:81703511
- 批准年份:2017
- 资助金额:20.1 万元
- 项目类别:青年科学基金项目
基于肠道菌群探讨吴茱萸碱对肾性高血压大鼠VECs功能的影响及机制
- 批准号:81660048
- 批准年份:2016
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
- 批准号:
10662850 - 财政年份:2023
- 资助金额:
$ 17.71万 - 项目类别:
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis
肝纤维形成中的神经酰胺、AMPK 和 YAP/TAZ 信号转导
- 批准号:
10352024 - 财政年份:2022
- 资助金额:
$ 17.71万 - 项目类别:
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis
肝纤维形成中的神经酰胺、AMPK 和 YAP/TAZ 信号转导
- 批准号:
10544748 - 财政年份:2022
- 资助金额:
$ 17.71万 - 项目类别:
Microbiota-sourced purines in gut health and disease
微生物群来源的嘌呤在肠道健康和疾病中的作用
- 批准号:
10283449 - 财政年份:2021
- 资助金额:
$ 17.71万 - 项目类别:
Microbiota-sourced purines in gut health and disease
微生物群来源的嘌呤在肠道健康和疾病中的作用
- 批准号:
10475271 - 财政年份:2021
- 资助金额:
$ 17.71万 - 项目类别: